Spravato Treatment for Treatment-Resistant Depression
Spravato treatment is specifically indicated for adults diagnosed with treatment-resistant depression. Treatment-resistant depression is defined clinically as a major depressive disorder that has not responded adequately to at least two different antidepressant medications taken at adequate doses and duration.
Spravato treatment for depression is not a standalone intervention but rather a component of a comprehensive psychiatric treatment plan that may include ongoing antidepressant medication, psychotherapy, and regular psychiatric assessment. This non-invasive depression treatment approach is integrated into existing care plans under the guidance of a treating psychiatrist.
Who Is a Good Candidate for Spravato Therapy?
Eligibility for Spravato therapy is determined through a comprehensive psychiatric assessment conducted by a licensed psychiatrist. The evaluation process includes:
- Review of the patient's diagnosis
- Complete treatment history
- Previous medication trials
- Current symptom severity
- Overall health status
Candidates for Spravato treatment must have a confirmed diagnosis of treatment-resistant depression and must be currently taking an oral antidepressant medication. Spravato therapy requires a valid prescription and can only be administered in certified clinical settings with appropriate medical supervision. To begin the evaluation process, contact our Los Angeles mental health clinic to schedule an initial consultation with one of our psychiatrists.
How Spravato Therapy Works
Spravato therapy is administered exclusively in a clinical setting under direct medical supervision. During each treatment session, the patient self-administers esketamine nasal spray under the observation of healthcare staff at our Spravato clinic. Following administration, patients remain on-site for a minimum observation period during which vital signs are monitored, and any immediate effects are assessed by clinical staff. Patients are not permitted to drive following treatment and must arrange transportation home.
Spravato treatment typically follows a defined schedule that begins with more frequent sessions during an initial phase, potentially transitioning to less frequent maintenance sessions based on clinical response and physician assessment. Follow-up psychiatric visits are required throughout the course of Spravato therapy to assess tolerability, monitor symptoms, and adjust the overall treatment approach as clinically indicated.
How Our Spravato Approach Compares to Standard Providers
Spravato therapy in Los Angeles is available from multiple healthcare providers throughout the region. At Amae Health, our approach to Spravato treatment is characterized by psychiatrist-led care integrated within a comprehensive mental health treatment framework.
Our treatment model includes coordinated treatment planning that considers all aspects of a patient's psychiatric care. Patients receiving Spravato treatment for depression at our facility benefit from consistent monitoring by the same clinical team throughout their treatment course, facilitating continuity of care.
The Spravato therapy program at Amae Health is designed to function as one element of ongoing mental health treatment, with psychiatric oversight ensuring that all aspects of care are appropriately coordinated.
Spravato Therapy Cost & Insurance Coverage
The cost of Spravato therapy varies depending on insurance coverage and individual clinical circumstances. Most commercial insurance plans and Medicare provide coverage for Spravato treatment when medical necessity criteria are met and prior authorization is obtained.
The authorization process typically requires documentation of a treatment-resistant depression diagnosis, evidence of prior antidepressant trials, and confirmation that clinical eligibility criteria are satisfied. Patients should contact their insurance provider directly to verify coverage details and any applicable cost-sharing responsibilities.
For patients without insurance coverage, self-pay options are available. Our administrative staff can provide information about the authorization process and payment arrangements during the initial consultation.
Spravato Therapy in Los Angeles – Our Clinic
Amae Health's Spravato clinic is located in Los Angeles and provides accessible outpatient mental health care to individuals throughout the greater Los Angeles area. Our facility is equipped to provide on-site administration of Spravato therapy in accordance with regulatory requirements. All treatment sessions occur at our Los Angeles location under the supervision of trained clinical staff, with psychiatrists available for consultation as needed. Patients receiving Spravato treatment at our Los Angeles clinic benefit from continuity of care, with the same treatment team providing consistent support throughout therapy.
Why Choose Our Spravato Program
Spravato therapy at Amae Health is delivered according to established clinical protocols with emphasis on patient safety and appropriate medical oversight. Our program features psychiatrist-led care, ensuring that licensed physicians make all treatment decisions with specialized psychiatric training.
Patient monitoring is conducted systematically during each treatment session, with clinical staff trained to identify and respond to any adverse effects. Our approach to Spravato treatment prioritizes safety-focused clinical processes, including pre-treatment evaluation, standardized administration procedures, post-treatment observation, and ongoing psychiatric assessment.
To schedule a consultation regarding Spravato therapy or to discuss eligibility for treatment, contact Amae Health's Los Angeles clinic. Our administrative staff can provide information about the evaluation process, insurance authorization requirements, and appointment scheduling.
